BioInsights - Scale-up and scale-out - what do we really need and how will we get there? - spotlight

CELL & GENE THERAPY INSIGHTS

Scale-up and scale-out - what do we really need and how will we get there?

September 2021

Download full spotlight

cGMP manufacturing made easy: a case study by ElevateBio

M Paglia,

S Eaker

24 November 2021

Innovator Insight

Read more
Viral vector gene delivery: balancing safety, efficacy and dose

T Gerritzen

1 October 2021

Viewpoint

Read more
Reaping the benefits in scalability: the flexibility of an in-house gene therapy manufacturing strategy

A Forbes

15 October 2021

Interview

Read more
Scale-up and scale-out: what do we really need and how will we get there?

J Thirkettle

15 October 2021

Foreword

Read more
From start-up to scale-up: a journey through AAV process development

K Mouillesseaux

5 October 2021

Viewpoint

Read more
Improving the yield of rAAV manufacturing with HeLa producer cells lines to ensure patient access

M Fuller

5 October 2021

Editorial

Read more
Expert Roundtable: overcoming challenges in analytical assays for cellular therapies

J Joedicke,

E PhD,

M Mues

13 October 2021

Expert Roundtable

Read more
Expert Roundtable: evolution in AAV process development: 2022 and beyond

A Becerra,

M Hebben,

M Mercaldi

12 October 2021

Expert Roundtable

Read more
Expert Roundtable: overcoming challenges in analytical assays for cellular therapies

J Joedicke,

E PhD,

M Mues

11 October 2021

Expert Roundtable Video

Watch now
Expert Roundtable: evolution in AAV process development: 2022 and beyond

A BECERRA,

M Hebben,

M Mercaldi

11 October 2021

Expert Roundtable Video

Watch now
Scaling up viral vector production: the importance of quality

J Lacouchie

5 October 2021

Interview

Read more
Cell and gene manufacturing: a case study approach to overcoming challenges – understanding the value of an expert supplier

S Werner,

A Shields

4 October 2021

FastFacts

Read more
Scaling-up the production of stem cell-derived extracellular vesicles in stirred-tank bioreactors

A Tacheny

29 September 2021

Innovator Insight

Read more
Scalable downstream process development for in vivo gene therapy products: understanding full/empty separation capabilities and challenges with ion exchange chromatography

K Dhanasekharan

29 September 2021

Expert Insight

Read more
Industrializing viral vector manufacture

D Teasley,

K Schewe

15 September 2021

Interview

Read more
Applying a closed, modular, semi-automated system to CAR T cell therapy manufacturing

Y Ji

14 September 2021

Innovator Insight

Read more
Getting closer to the in vivo environment with human AB serum

T Smith

31 August 2021

FastFacts

Read more
cGMP manufacturing made easy – a case study by ElevateBio

Michael Paglia, COO, ElevateBio, BaseCamp

Shannon Eaker, Cell and Gene Therapy Enterprise Solutions and FastTrak Leader, Cytiva

14 October 2021

Webinar

Watch now
GMP manufacturing for exosome-based therapies: the critical role of analytics and process design for clinical production and scale-up

Marcos Langtry, Head of Allogeneic Cell Therapy Commercial Development, Lonza Pharma & Biotech

Davide Zocco, Research & Development Senior Manager, Lonza Pharma & Biotech

28 September 2021

Webinar

Watch now
Get your non-viral T cell engineering process ready for clinical manufacturing

Melanie Rietenbach, Global Product Manager Miltenyi Biotec

Stefan Wild, Senior Manager, Research and Development, Miltenyi Biotec

Kunal Patel, Process Engineering Manager, Miltenyi Biotec

21 September 2021

Webinar

Watch now
AAV manufacturing with stable producer cells for industrial scale vector production

Ben Hudjetz, PhD, Senior Scientist, Cell Line Development, CEVEC Pharmaceuticals GmbH

16 September 2021

Webinar

Watch now
Scalable, flexible manufacture: simplifying cell & gene therapy production

8 September 2021

Webinar

Watch now